Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rituximab and Non-Myeloablative Stem Cell Transplant for B-Cell Malignancies
NCT00425802Phase 2Completed
- Sponsor
- Memorial Sloan Kettering Cancer Center
- Start
- Nov 2006
- Primary completion
- Oct 2016
- Modality
- Monoclonal Antibodies
- Countries
- 1
01
Overview
A Phase 2 trial of rituximab in B-cell non-Hodgkin lymphoma, chronic lymphocytic leukemia (CLL), sponsored by Memorial Sloan Kettering Cancer Center. Started Nov 2006; status: completed.
02
Drugs
rituximab
03
Conditions
B-cell non-Hodgkin lymphomachronic lymphocytic leukemia (CLL)
Beyond the preview
Go deeper on NCT00425802.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00425802.